Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with [18-F]-fluorodeoxyglucose and [11C]-methionine tracers

Citation
N. Tsuyuguchi et al., Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with [18-F]-fluorodeoxyglucose and [11C]-methionine tracers, AM J NEUROR, 22(2), 2001, pp. 311-313
Citations number
14
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
Journal title
AMERICAN JOURNAL OF NEURORADIOLOGY
ISSN journal
01956108 → ACNP
Volume
22
Issue
2
Year of publication
2001
Pages
311 - 313
Database
ISI
SICI code
0195-6108(200102)22:2<311:EOPXBU>2.0.ZU;2-5
Abstract
We present a case of pleomorphic xanthoastrocytoma (PXA) in a patient with temporal lobe seizures. Imaging sequences included MR, and results of posit ron emission tomography (PET) with [18F]-fluorodeoxyglucose (FDG) and [11C] -methionine (Met) tracers revealed a hypermetabolic region equivalent or ne arly equivalent to normal cerebral cortex, suggesting that the tumor might have malignant potential, Histopathologic findings indicated low-grade glio ma. The mechanism for glucose hypermetabolic activity of PXA is not clear; however, the positive findings obtained from FDG-PET may not always indicat e the degree of malignancy associated with PXA.